Montoya T Ignacio, Acevedo Jesus F, Smith Benjamin, Keller Patrick W, Sailors Joseph L, Tang Liping, Word R Ann, Wai Clifford Y
Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX, 75390-9032, USA.
Int Urogynecol J. 2015 Jun;26(6):893-904. doi: 10.1007/s00192-014-2620-6. Epub 2015 Feb 3.
To evaluate the effect of myogenic stem cell-laden hydrogel scaffold on contractile function and histomorphology of the external anal sphincter (EAS) after transection without repair.
Eighty female rats underwent anal sphincter transection without repair. After 2 weeks, animals were injected at the transection site with: nothing (non-repaired control, NRC group); a polyethylene glycol-based hydrogel matrix scaffold combined with phosphate-buffered saline (PBS/hydrogel group); a hydrogel matrix scaffold combined with myogenic stem cells (stem cell/hydrogel group): or type I collagen (collagen) group. 4 (n = 40) or 12 (n = 40) weeks later, the anal sphincter complexes were dissected out and analyzed for contractile function, disruption, and striated muscle volume. Time-matched unoperated controls (UOC) were utilized for each of the two time points (n = 20).
After 4 weeks, maximal electrical field-stimulated (EFS) contractions were significantly decreased in all four non-repaired treatment groups compared with UOC. However, EFS-stimulated contractions, tetanic force generation, and twitch tension were improved in non-repaired EAS injected with stem cell/hydrogel group relative to the NRC, PBS/hydrogel, or collagen groups. NRC and sphincters injected with PBS/hydrogel deteriorated further by 12 weeks, while those receiving stem cell/hydrogel maintained improved contractile function at varying frequencies and voltages. Striated muscle volume increased from 4 to 12 weeks for PBS/hydrogel and stem cell/hydrogel animals. At 12 weeks, stem cell/hydrogel animals had greater sphincter striated muscle volumes compared with all other treatment groups.
In this animal model, sustained improvement of contractile responses in non-repaired EAS treated with biogel scaffold and myogenic stem cells suggests that a biologically compatible matrix may facilitate stem cell survival, differentiation, or function leading to recovery of contractile function even after persistent disruption.
评估负载成肌干细胞的水凝胶支架对肛门外括约肌(EAS)横断后未修复时收缩功能和组织形态学的影响。
80只雌性大鼠接受肛门括约肌横断且未修复。2周后,在横断部位注射:无(未修复对照组,NRC组);聚乙二醇基水凝胶基质支架联合磷酸盐缓冲盐水(PBS/水凝胶组);水凝胶基质支架联合成肌干细胞(干细胞/水凝胶组);或I型胶原蛋白(胶原蛋白组)。4周(n = 40)或12周(n = 40)后,解剖肛门括约肌复合体,分析其收缩功能、完整性及横纹肌体积。两个时间点均使用时间匹配的未手术对照(UOC)(n = 20)。
4周后,与UOC相比,所有四个未修复治疗组的最大电场刺激(EFS)收缩均显著降低。然而,相对于NRC、PBS/水凝胶或胶原蛋白组,注射干细胞/水凝胶组的未修复EAS中EFS刺激的收缩、强直力产生和抽搐张力有所改善。NRC组和注射PBS/水凝胶的括约肌在12周时进一步恶化,而接受干细胞/水凝胶治疗的括约肌在不同频率和电压下保持改善的收缩功能。PBS/水凝胶组和干细胞/水凝胶组动物的横纹肌体积从4周增加到12周。在12周时,与所有其他治疗组相比,干细胞/水凝胶组动物的括约肌横纹肌体积更大。
在该动物模型中,用生物凝胶支架和成肌干细胞治疗的未修复EAS的收缩反应持续改善,表明生物相容性基质可能促进干细胞存活、分化或功能,即使在持续破坏后也能导致收缩功能恢复。